Saturday 10/16/21
LINKED WITH BLOOD CLOTS

EU contract with AstraZeneca on Covid-19 jabs to run out in June

On Saturday, the EU Commission struck a deal with Pfizer/BioNTech to buy up to 1.8 billion additional doses until 2023.
03 May 2021, Australia, Perth: A nurse holds up a syringe containing the AstraZeneca COVID-19 vaccine at the Claremont Showground centre during a mass vaccination campaign. Photo: Richard Wainwright/AAP/dpa
A nurse holds up a syringe containing the AstraZeneca COVID-19 vaccine. Photo: Richard Wainwright/dpa.

The European Union has not extended a contract for Covid-19 vaccines with British-Swedish manufacturer AstraZeneca, Internal Market Commissioner Thierry Breton said on Sunday.

"We have not extended the order beyond the month of June," Breton told French broadcaster France Inter with regards to AstraZeneca.

"We will see. We will see what happens," he said.

AstraZeneca's Covid-19 vaccine has been linked with a very rare risk of potential blood clots, especially for younger women, resulting in some countries restricting its use to only older age groups.

Breton expressed a positive view about the quality of AstraZeneca's shot.

"This is a good vaccine," he said.

On Saturday, the European Commission struck a deal with Covid-19 vaccine producer Pfizer/BioNTech to buy up to 1.8 billion additional doses until 2023.

Comments